Literature DB >> 24161406

Potential of handheld optical coherence tomography to determine cause of infantile nystagmus in children by using foveal morphology.

Helena Lee1, Viral Sheth1, Mashal Bibi1, Gail Maconachie1, Aarti Patel1, Rebecca J McLean1, Michel Michaelides2, Mervyn G Thomas1, Frank A Proudlock1, Irene Gottlob3.   

Abstract

OBJECTIVE: To investigate the feasibility of handheld (HH) ultra-high-resolution spectral-domain optical coherence tomography (SD-OCT) in young children with nystagmus, to determine its sensitivity and specificity in classifying foveal abnormalities, and to investigate its potential to determine the cause of infantile nystagmus with the use of foveal morphology.
DESIGN: Prospective, case-control study. PARTICIPANTS AND CONTROLS: A total of 50 patients with nystagmus and 50 healthy control subjects (mean age, 3.2 years; range, 0-8 years).
METHODS: Each patient was scanned using HH SD-OCT (Bioptigen Inc., Research Triangle Park, NC) without sedation, and foveal morphology was classified into 1 of 4 categories: (1) typical foveal hypoplasia (predicting clinical diagnosis of albinism, PAX6 mutations, or isolated foveal hypoplasia); (2) atypical foveal hypoplasia (predicting achromatopsia); (3) other foveal changes (corresponding to retinal dystrophies); and (4) normal fovea (predicting idiopathic or manifest latent nystagmus). An independent interpretation of the HH SD-OCT scans by masked examiners was performed, and the sensitivity and specificity of the predicted diagnosis were calculated. MAIN OUTCOME MEASURES: The success rate of image acquisition and sensitivity and specificity of the HH SD-OCT in classifying foveal abnormalities.
RESULTS: In 94% of examinations, HH SD-OCT was successful. Twenty-three patients had typical foveal hypoplasia (category 1). Of these patients, 21 were diagnosed with albinism and 2 were diagnosed with PAX6 mutations. Five patients were classified as atypical (category 2) and diagnosed with achromatopsia. Six patients had other abnormal foveal morphology (category 3) and were diagnosed with retinal dystrophy. Sixteen patients had normal foveal morphology (category 4). Of these patients, 12 were diagnosed with idiopathic nystagmus and 4 were diagnosed with manifest latent nystagmus. Sensitivities of HH SD-OCT for classifying typical or atypical foveal hypoplasia, other abnormal foveal morphology, and normal morphology were 92.8%, 86.7%, 41.1%, and 88.4%, respectively, with specificities of 91.4%, 94.8%, 97.7% and 95.1%, respectively.
CONCLUSIONS: We demonstrate excellent feasibility of HH SD-OCT in the diagnosis of conditions associated with infantile nystagmus. The HH SD-OCT classification of foveal abnormalities was highly sensitive and specific. This classification was used to determine the underlying cause of infantile nystagmus. Handheld SD-OCT in early childhood can facilitate focused investigations and earlier diagnosis. This is important in an era when potentially time-sensitive treatment, such as gene therapy, is imminent.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24161406     DOI: 10.1016/j.ophtha.2013.07.018

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Reproducibility of circumpapillary retinal nerve fiber layer measurements using handheld optical coherence tomography in sedated children.

Authors:  Robert A Avery; Avital Cnaan; Joel S Schuman; Chieh-Li Chen; Natalie C Glaug; Roger J Packer; Graham E Quinn; Hiroshi Ishikawa
Journal:  Am J Ophthalmol       Date:  2014-06-28       Impact factor: 5.258

Review 2.  The clinical evaluation of infantile nystagmus: What to do first and why.

Authors:  Morgan Bertsch; Michael Floyd; Taylor Kehoe; Wanda Pfeifer; Arlene V Drack
Journal:  Ophthalmic Genet       Date:  2017 Jan-Feb       Impact factor: 1.803

3.  Accuracy of Next-Generation Sequencing for Molecular Diagnosis in Patients With Infantile Nystagmus Syndrome.

Authors:  John Hoon Rim; Seung-Tae Lee; Heon Yung Gee; Byung Joo Lee; Jong Rak Choi; Hye Won Park; Sueng-Han Han; Jinu Han
Journal:  JAMA Ophthalmol       Date:  2017-12-01       Impact factor: 7.389

Review 4.  Applications of optical coherence tomography in pediatric clinical neuroscience.

Authors:  Robert A Avery; Raneem D Rajjoub; Carmelina Trimboli-Heidler; Amy T Waldman
Journal:  Neuropediatrics       Date:  2015-03-24       Impact factor: 1.947

5.  Spectral-domain optical coherence tomography findings in Alström syndrome.

Authors:  Gad Dotan; Vikas Khetan; Jan D Marshall; Elizabeth Affel; Denise Armiger-George; Jürgen K Naggert; Gayle B Collin; Alex V Levin
Journal:  Ophthalmic Genet       Date:  2017-01-23       Impact factor: 1.803

6.  Handheld optical coherence tomography removes barriers to imaging the eyes of young children.

Authors:  Sohaib R Rufai
Journal:  Eye (Lond)       Date:  2022-01-10       Impact factor: 4.456

7.  Measurement of macular thickness with optical coherence tomography: impact of using a paediatric reference database and analysis of interocular symmetry.

Authors:  Alicia Muñoz-Gallego; José L Torres-Peña; Martín Rodríguez-Salgado; Ana Ortueta-Olartecoechea; Cristina López-López; Javier De la Cruz; Pilar Tejada-Palacios
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-29       Impact factor: 3.117

8.  Clinical utility gene card for: Aniridia.

Authors:  Rose Richardson; Melanie Hingorani; Veronica Van Heyningen; Cheryl Gregory-Evans; Mariya Moosajee
Journal:  Eur J Hum Genet       Date:  2016-07-06       Impact factor: 4.246

Review 9.  Retinal Imaging of Infants on Spectral Domain Optical Coherence Tomography.

Authors:  Anand Vinekar; Shwetha Mangalesh; Chaitra Jayadev; Ramiro S Maldonado; Noel Bauer; Cynthia A Toth
Journal:  Biomed Res Int       Date:  2015-07-06       Impact factor: 3.411

10.  Is handheld optical coherence tomography reliable in infants and young children with and without nystagmus?

Authors:  Helena Lee; Frank Proudlock; Irene Gottlob
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.